PROTEOMICS PROFILING OF BREAST CANCER PATIENTS RECEIVING TAMOXIFEN

被引：0
|
作者：
Johansson, H. J. [2 ]
Sanchez, B. Chavez [1 ]
Bergh, J. [3 ,4 ,5 ]
Linderholm, B.
Lehtio, J.
机构：
[1] Karolinska Inst, Dept Oncol Pathol, KBC, Stockholm, Sweden
[2] Univ Hosp, KBC, Stockholm, Sweden
[3] Karolinska Hosp, Clin & Translat Res, S-10401 Stockholm, Sweden
[4] Univ Manchester, Manchester, Lancs, England
[5] Christie Med Oncol Breast Unit, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70P
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [41] Functional Proteomics of Breast Cancer for Signal Pathway Profiling and Target Discovery
    Hubert Hondermarck
    Laurent Dollé
    Ikram El Yazidi-Belkoura
    Anne-Sophie Vercoutter-Edouart
    Eric Adriaenssens
    Jérôme Lemoine
    [J]. Journal of Mammary Gland Biology and Neoplasia, 2002, 7 : 395 - 405
  • [42] Functional proteomics of breast cancer for signal pathway profiling and target discovery
    Hondermarck, H
    Dollé, L
    El Yazidi-Belkoura, I
    Vercoutter-Edouart, AS
    Adriaenssens, E
    Lemoine, J
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2002, 7 (04) : 395 - 405
  • [43] The proteomics profiling of molecular targets of tocotrienols in human breast cancer cells
    Abdul-Rahman, P. S.
    Ramdass, P.
    Sani, A. A. Abdu
    Radhakrishnan, A.
    [J]. FEBS JOURNAL, 2016, 283 : 122 - 123
  • [44] Proteomics-based characterization of pathways involved in tamoxifen resistance in breast cancer cells
    Sanchez, Betzabe C.
    Johansson, Henrik
    Lehtio, Janne
    Stal, Olle
    Linderholm, Barbro K.
    [J]. CANCER RESEARCH, 2010, 70
  • [45] Proteomics-based characterization of potential biomarkers in tamoxifen resistance in breast cancer.
    Sanchez, B. C.
    Johansson, H.
    Forshed, J.
    Stal, O.
    Lehtio, J.
    Linderholm, B. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance
    Besada, V
    Diaz, M
    Becker, M
    Ramos, Y
    Castellanos-Serra, L
    Fichtner, I
    [J]. PROTEOMICS, 2006, 6 (03) : 1038 - 1048
  • [47] Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer
    Iwata, Hiroji
    Masuda, Norikazu
    Sagara, Yasuaki
    Kinoshita, Takayuki
    Nakamura, Seigo
    Yanagita, Yasuhiro
    Nishimura, Reiki
    Iwase, Hirotaka
    Kamigaki, Shunji
    Takei, Hiroyuki
    Tsuda, Hitoshi
    Hayashi, Nobuya
    Noguchi, Shinzaburo
    [J]. CANCER, 2013, 119 (04) : 704 - 713
  • [48] Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy
    Nowell, S
    Sweeney, C
    Winters, M
    Stone, A
    Lang, NP
    Hutchins, LF
    Kadlubar, FF
    Ambrosone, CB
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (21) : 1635 - 1640
  • [49] MATURATION OF VAGINAL AND ENDOMETRIAL EPITHELIUM IN POSTMENOPAUSAL BREAST-CANCER PATIENTS RECEIVING LONG-TERM TAMOXIFEN
    LAHTI, E
    VUOPALA, S
    KAUPPILA, A
    BLANCO, G
    RUOKONEN, A
    LAATIKAINEN, T
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 55 (03) : 410 - 414
  • [50] Menopausal symptoms and uterine changes in postmenopausal breast cancer patients receiving tamoxifen or third generation aromatase inhibitors
    不详
    [J]. EJC SUPPLEMENTS, 2004, 2 (09): : 19 - 21
12345